← Leaderboards
Charles M Perou
Univ Of North Carolina Chapel Hill
$46,508,459
Attributed
$71,917,523
Total exposure
27
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$90,025,476 · 28
By mechanism
P50$26,735,855 · 8
U24$25,759,141 · 2
R01$16,750,609 · 8
P30$7,388,952 · 5
U01$5,162,086 · 3
UG1$4,818,439 · 1
Top collaborators
- David N Hayes20 shared
- Jeffrey Rosen18 shared
- Melissa A. Troester10 shared
- Jason Derek Merker7 shared
- Lisa A Carey6 shared
- Henry Shelton Earp5 shared
- Timothy C Elston5 shared
- Norman Edward Sharpless3 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Donglin Zeng$2,201,289
- Lisa A Carey$11,034,788
- Joseph G Ibrahim$17,599,307
Others in their field
Top investigators on “Genomics”
- Eric S Lander · Whitehead Institute For Biomedical Res$790,826,794
- Richard A Gibbs · Baylor College Of Medicine$661,700,875
- Richard K. Wilson · Washington University$497,388,134
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- David Heimbrook · Leidos Biomedical Research, Inc.$333,649,126
- Stacey Gabriel · Massachusetts Institute Of Technology$331,896,891
Research focus
GenomicsTumorMalignant Breast NeoplasmGenesBaseGene ExpressionResponseMalignant NeoplasmsGene Expression ProfilingTechnologyClinical TrialsBreastCellsSpecimenTranslational ResearchPathway InteractionsResearch PersonnelPharmaceutical PreparationsBioinformaticsProteinsSamplingMutationMammary NeoplasmsTriple-Negative Invasive Breast Carcinoma
Grant awards (133)
SPORE in Breast Cancer$2,348,589
P50 · FY2025 · CA · contact PI
Elucidating the molecular mechanisms of metastasis organ tropism$639,882
U01 · FY2025 · CA · contact PI
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$600,941
UG1 · FY2025 · CA
Optimizing prognostic and predictive algorithms using residual disease (RD) genomic biomarkers in HER2+ and TNBC$596,748
R01 · FY2025 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$413,297
R01 · FY2025 · CA · contact PI
Bioinformatics$405,443
P30 · FY2025 · CA · contact PI
Project 3: Development of Novel Therapies and Biomarkers for TNBC Patients$365,447
P50 · FY2025 · CA · contact PI
Administrative Core$197,951
P50 · FY2025 · CA · contact PI
SPORE in Breast Cancer$2,268,690
P50 · FY2024 · CA · contact PI
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$637,440
UG1 · FY2024 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$392,632
R01 · FY2024 · CA · contact PI
Project 3: Development of Novel Therapies and Biomarkers for TNBC Patients$358,272
P50 · FY2024 · CA · contact PI
Bioinformatics$355,463
P30 · FY2024 · CA · contact PI
Administrative Core$194,063
P50 · FY2024 · CA · contact PI
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$728,371
UG1 · FY2023 · CA
Predictive Modeling of the EGFR-MAPK pathway for Triple Negative Breast Cancer Patients$557,886
U01 · FY2023 · CA · contact PI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$413,297
R01 · FY2023 · CA · contact PI
Bioinformatics$394,962
P30 · FY2023 · CA · contact PI
SPORE in Breast Cancer$2,324,485
P50 · FY2022 · CA · contact PI
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$663,338
UG1 · FY2022 · CA
Predictive Modeling of the EGFR-MAPK pathway for Triple Negative Breast Cancer Patients$559,954
U01 · FY2022 · CA · contact PI
Project 3: Chemotherapy and Immunotherapy Biomarker Development for Triple Negative Breast Cancer$469,334
P50 · FY2022 · CA · contact PI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$405,031
R01 · FY2022 · CA · contact PI
Bioinformatics$394,962
P30 · FY2022 · CA · contact PI
SPORE in Breast Cancer$2,323,936
P50 · FY2021 · CA · contact PI
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$728,348
UG1 · FY2021 · CA
Predictive Modeling of the EGFR-MAPK pathway for Triple Negative Breast Cancer Patients$572,275
U01 · FY2021 · CA · contact PI
Project 3: Chemotherapy and Immunotherapy Biomarker Development for Triple Negative Breast Cancer$469,225
P50 · FY2021 · CA · contact PI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$413,297
R01 · FY2021 · CA · contact PI
Bioinformatics$394,962
P30 · FY2021 · CA · contact PI
SPORE in Breast Cancer$2,293,534
P50 · FY2020 · CA · contact PI
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$730,001
UG1 · FY2020 · CA
Predictive Modeling of the EGFR-MAPK pathway for Triple Negative Breast Cancer Patients$694,019
U01 · FY2020 · CA · contact PI
Bioinformatics$477,782
P30 · FY2020 · CA · contact PI
Project 3: Chemotherapy and Immunotherapy Biomarker Development for Triple Negative Breast Cancer$463,085
P50 · FY2020 · CA · contact PI
SPORE in Breast Cancer$2,323,522
P50 · FY2019 · CA · contact PI
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$730,000
UG1 · FY2019 · CA · contact PI
Predictive Modeling of the EGFR-MAPK pathway for Triple Negative Breast Cancer Patients$572,275
U01 · FY2019 · CA · contact PI
Bioinformatics$463,115
P30 · FY2019 · CA · contact PI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$418,717
R01 · FY2019 · CA · contact PI
Project 3: Chemotherapy and Immunotherapy Biomarker Development for Triple Negative Breast Cancer$258,169
P50 · FY2019 · CA · contact PI
SPORE in Breast Cancer$2,499,932
P50 · FY2018 · CA · contact PI
Network Group Integrated Translational Science Centers Application$610,519
U10 · FY2018 · CA · contact PI
Project 3: Chemotherapy and Immunotherapy Biomarker Development for Triple Negative Breast Cancer$504,759
P50 · FY2018 · CA · contact PI
Bioinformatics$477,784
P30 · FY2018 · CA · contact PI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$431,667
R01 · FY2018 · CA · contact PI
Biology of Race and Progression Associated Breast Tumor Gene Expression$313,159
U01 · FY2018 · CA
Bioinformatics$2,968
P30 · FY2018 · CA · contact PI
Bioinformatics$2,103
P30 · FY2018 · CA · contact PI
Bioinformatics$1,367
P30 · FY2018 · CA · contact PI
Network Group Integrated Translational Science Centers Application$699,875
U10 · FY2017 · CA · contact PI
Credentialing Mouse Models for Immune System Therapy Research$581,304
R01 · FY2017 · CA · contact PI
Mouse Models of Metastatic Triple-Negative Breast Cancer for Therapeutic Testing$569,391
R01 · FY2017 · CA · contact PI
Bioinformatics$468,720
P30 · FY2017 · CA · contact PI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$393,933
R01 · FY2017 · CA · contact PI
Biology of Race and Progression Associated Breast Tumor Gene Expression$313,159
U01 · FY2017 · CA
SPORE in Breast Cancer$1,725,265
P50 · FY2016 · CA · contact PI
Network Group Integrated Translational Science Centers Application$700,000
U10 · FY2016 · CA
Credentialing Mouse Models for Immune System Therapy Research$581,304
R01 · FY2016 · CA · contact PI
Mouse Models of Metastatic Triple-Negative Breast Cancer for Therapeutic Testing$572,521
R01 · FY2016 · CA · contact PI
Bioinformatics$471,524
P30 · FY2016 · CA · contact PI
(PQD5) Predicting Anti-Cancer Efficacy through Tumor Profiling$405,890
R01 · FY2016 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$393,933
R01 · FY2016 · CA · contact PI
Development and Validation of Biomarkers and Targets in Triple Negative Breast Ca$368,211
P50 · FY2016 · CA · contact PI
Biology of Race and Progression Associated Breast Tumor Gene Expression$313,159
U01 · FY2016 · CA
Genomics, Biostatistics & Bioinformatics$226,336
P50 · FY2016 · CA · contact PI
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$151,313
U24 · FY2016 · CA · contact PI
Network Group Integrated Translational Science Centers Application$700,000
U10 · FY2015 · CA
Credentialing Mouse Models for Immune System Therapy Research$588,966
R01 · FY2015 · CA · contact PI
Mouse Models of Metastatic Triple-Negative Breast Cancer for Therapeutic Testing$588,590
R01 · FY2015 · CA · contact PI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$406,933
R01 · FY2015 · CA · contact PI
(PQD5) Predicting Anti-Cancer Efficacy through Tumor Profiling$405,890
R01 · FY2015 · CA
Development and Validation of Biomarkers and Targets in Triple Negative Breast Ca$323,830
P50 · FY2015 · CA · contact PI
Biology of Race and Progression Associated Breast Tumor Gene Expression$313,159
U01 · FY2015 · CA
Bioinformatics Core Facility$279,216
P30 · FY2015 · CA · contact PI
Genomics, Biostatistics & Bioinformatics$193,483
P50 · FY2015 · CA · contact PI
Network Group Integrated Translational Science Centers Application$700,000
U10 · FY2014 · CA
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$500,000
U24 · FY2014 · CA · contact PI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$471,844
R01 · FY2014 · CA
(PQD5) Predicting Anti-Cancer Efficacy through Tumor Profiling$405,890
R01 · FY2014 · CA
Biology of Race and Progression Associated Breast Tumor Gene Expression$313,159
U01 · FY2014 · CA
Bioinformatics Core Facility$275,193
P30 · FY2014 · CA · contact PI
Development and Validation of Biomarkers and Targets in Triple Negative Breast Ca$251,747
P50 · FY2014 · CA · contact PI
Genomics, Biostatistics & Bioinformatics$164,694
P50 · FY2014 · CA · contact PI
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$3,777,133
U24 · FY2013 · CA · contact PI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$459,677
R01 · FY2013 · CA
Bioinformatics Core Facility$275,963
P30 · FY2013 · CA · contact PI
Development and Validation of Biomarkers and Targets in Triple Negative Breast Ca$250,603
P50 · FY2013 · CA · contact PI
Genomics, Biostatistics & Bioinformatics$163,945
P50 · FY2013 · CA · contact PI
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$3,802,733
U24 · FY2012 · CA · contact PI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$491,675
R01 · FY2012 · CA
Conserved Biology of Tumor and Microenvironment in Breast Cancer Progression$455,204
R01 · FY2012 · CA · contact PI
Bioinformatics Core Facility$281,657
P30 · FY2012 · CA · contact PI
Genomics, Biostatistics & Bioinformatics$190,272
P50 · FY2012 · CA · contact PI
Development and Validation of Biomarkers and Targets in Triple Negative Breast Ca$182,329
P50 · FY2012 · CA · contact PI
Bioinformatics Core Facility$2,552
P30 · FY2012 · CA · contact PI
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$3,916,513
U24 · FY2011 · CA · contact PI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$494,417
R01 · FY2011 · CA
Conserved Biology of Tumor and Microenvironment in Breast Cancer Progression$464,025
R01 · FY2011 · CA · contact PI
Bioinformatics Core Facility$286,287
P30 · FY2011 · CA · contact PI
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$4,161,072
U24 · FY2010 · CA · contact PI
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$834,674
U24 · FY2010 · CA · contact PI
Breast CancerTherapeutic Subtype Therapeutic Responses: Eval. of Chemo. and Bio.$518,816
P50 · FY2010 · CA · contact PI
Conserved Biology of Tumor and Microenvironment in Breast Cancer Progression$492,602
R01 · FY2010 · CA · contact PI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells$464,834
R01 · FY2010 · CA
Target Validation and Drug Development with Aptamers for Basal-like Breast Cancer$304,874
R01 · FY2010 · CA
Genomics, Genotyping, and Bioinformatics$129,690
P50 · FY2010 · CA · contact PI
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$3,699,532
U24 · FY2009 · CA · contact PI
Breast CancerTherapeutic Subtype Therapeutic Responses: Eval. of Chemo. and Bio.$519,479
P50 · FY2009 · CA · contact PI
Conserved Biology of Tumor and Microenvironment in Breast Cancer Progression$497,318
R01 · FY2009 · CA · contact PI
CORE--GENOMICS AND BIOINFORMATICS$435,865
P30 · FY2009 · CA · contact PI
Target Validation and Drug Development with Aptamers for Basal-like Breast Cancer$313,475
R01 · FY2009 · CA
Cancer Genome Characterization using Gene Expression and DNA Copy Number Analysis$300,000
U24 · FY2009 · CA · contact PI
Genomics, Genotyping, and Bioinformatics$129,856
P50 · FY2009 · CA · contact PI
Cancer Genome Characterization using Gene Expression and DNA Copy Number Analysis$1,503,673
U24 · FY2008 · CA · contact PI
Breast CancerTherapeutic Subtype Therapeutic Responses: Eval. of Chemo. and Bio.$520,046
P50 · FY2008 · CA · contact PI
Conserved Biology of Tumor and Microenvironment in Breast Cancer Progression$482,800
R01 · FY2008 · CA · contact PI
CORE--GENOMICS AND BIOINFORMATICS$436,336
P30 · FY2008 · CA · contact PI
Genomics, Genotyping, and Bioinformatics$130,002
P50 · FY2008 · CA · contact PI
Cancer Genome Characterization using Gene Expression and DNA Copy Number Analysis$1,488,904
U24 · FY2007 · CA · contact PI
Breast CancerTherapeutic Subtype Therapeutic Responses: Eval. of Chemo. and Bio.$507,580
P50 · FY2007 · CA · contact PI
CORE--GENOMICS AND BIOINFORMATICS$415,762
P30 · FY2007 · CA · contact PI
Molecular Characterization of Breast Basal-like Tumors$410,692
R01 · FY2007 · CA · contact PI
Genomics, Genotyping, and Bioinformatics$126,887
P50 · FY2007 · CA · contact PI
Cancer Genome Characterization using Gene Expression and DNA Copy Number Analysis$1,623,594
U24 · FY2006 · CA · contact PI
Molecular Characterization of Breast Basal-like Tumors$410,643
R01 · FY2006 · CA · contact PI
Breast CancerTherapeutic Subtype Therapeutic Responses: Eval. of Chemo. and Bio.$357,898
P50 · FY2006 · CA · contact PI
CORE--GENOMICS AND BIOINFORMATICS$197,357
P30 · FY2006 · CA · contact PI
Genomics, Genotyping, and Bioinformatics$91,893
P50 · FY2006 · CA · contact PI
Molecular Characterization of Breast Basal-like Tumors$408,275
R01 · FY2005 · CA
CORE--GENOMICS AND BIOINFORMATICS$191,609
P30 · FY2005 · CA
Molecular Characterization of Breast Basal-like Tumors$396,382
R01 · FY2004 · CA
Molecular Characterization of Breast Basal-like Tumors$352,641
R01 · FY2003 · CA